Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

An estimated 32 million people in the United States have COPD. As many as half are unaware that they have it. These diseases include emphysema and chronic bronchitis. Many people with COPD have both.

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people ...

Chronic bronchitis is part of a group of conditions called chronic obstructive pulmonary disease (COPD). COPD also includes chronic emphysema. Additional symptoms of COPD, including chronic ...

COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. The disease ...

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people ...

Increased perceived stress is linked to worsened respiratory symptoms and decreased quality of life in individuals with ...

Patients were included regardless of symptoms of chronic bronchitis or COPD type (chronic bronchitis only, emphysema only, both, or neither). Patients needed to have a blood eosinophil count of at ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study.

Sanofi to showcases leadership and breadth of scientific innovation in chronic inflammatory respiratory conditions at ATS conference: Paris Saturday, May 3, 2025, 16:00 Hrs [IST] ...

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require ...